Showing results (281-290 of 317) with videos related to

Sort By:
Pageof 32
JAMA Oncology|June 17, 2021
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19Michael A Thompson, Jeffrey P Henderson, Pankil K Shah, et al.
European Urology|May 22, 2025
Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder CancerMarie-Pier St-Laurent, Parminder Singh, David J McConkey, et al.
JCO Precision Oncology|December 5, 2025
Impact of SPOP Mutations on Clinical Outcomes in Metastatic Prostate CancerDeepak Kilari, Nicholas C Henderson, Kyra Yamamoto, et al.
JAMA Network Open|September 18, 2023
Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate CancerClara Hwang, Nicholas C Henderson, Shih-Chun Chu, et al.
Nature Communications|September 10, 2025
Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancerKevin Chang, Henry M Delavan, Elizabeth Yip, et al.
European Urology Oncology|December 21, 2024
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study DataTanya Jindal, Cindy Jiang, Omar Alhalabi, et al.
JMIR Cancer|May 19, 2022
Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational StudyMaitri Kalra, Elizabeth Henry, Kelly McCann, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
BRD4-mediated epigenetic regulation of endoplasmic reticulum-mitochondria contact sites is governed by the mitochondrial complex IIIBrandon Chen, Drew C Stark, Pankaj V Jadhav, et al.
JCO Precision Oncology|April 5, 2024
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable AlterationsJoseph J Park, Alec Chu, Jinju Li, et al.
Urologic Oncology|October 28, 2025
Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE studyTanya Jindal, Cindy Y Jiang, Omar Alhalabi, et al.
Pageof 32